BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Silva KM, Ventura IB, Bolster MB, Castelino FV, Sharma A, Little BP, Adegunsoye A, Strek ME, Choi H, Montesi SB. Rituximab for interstitial pneumonia with autoimmune features at two medical centres. Rheumatol Adv Pract 2021;5:ii1-9. [PMID: 34755024 DOI: 10.1093/rap/rkab051] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Rzepka-wrona P, Skoczyński SM, Piotrowski W, Jassem E, Ziora D, Barczyk A. Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study (Preprint).. [DOI: 10.2196/preprints.44802] [Reference Citation Analysis]
2 Cleland D, Sathananthan M, Jeganathan N. Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice. Curr Pulmonol Rep 2022. [DOI: 10.1007/s13665-022-00296-4] [Reference Citation Analysis]
3 van den Bosch L, Luppi F, Ferrara G, Mura M. Immunomodulatory treatment of interstitial lung disease. Ther Adv Respir Dis 2022;16:17534666221117002. [PMID: 35938712 DOI: 10.1177/17534666221117002] [Reference Citation Analysis]